Wednesday 28 February 2024
Salisbury Foundation Trust

FOI_7189

Internal Reference Number: FOI_7189

Date Request Received: 19/05/2023 00:00:00

Date Request Replied To: 13/06/2023 00:00:00

This response was sent via: By Email

Request Summary: Endometrial cancer

Request Category: Private Individuals

 
Question Number 1:
Does your trust provide SACT (systemic anti-cancer therapy) treatments for endometrial cancer? If not, which other trust do you refer endometrial cancer patients to for SACT treatments?
 
Answer To Question 1:

YES
 
Question Number 2:
How many patients were treated for endometrial cancer in the past 6 months with the following treatments:

Dostarlimab

Hormone therapy (Progesterone or Letrozole)

Pembrolizumab monotherapy

Pembrolizumab in combination with Lenvatinib

Platinum-based chemotherapy (monotherapy or combination with taxanes, anthracyclines, cyclophosphamide)

Any other SACT
 
Answer To Question 2:

Dostarlimab 0
Hormone therapy (Progesterone or Letrozole) unable to answer
Pembrolizumab monotherapy 0
Pembrolizumab in combination with Lenvatinib 0
Platinum-based chemotherapy (monotherapy or combination with taxanes, anthracyclines, cyclophosphamide) <5
Any other SACT 0
 
Question Number 3:
How many endometrial cancer patients received the following therapies as 1st Line treatment in the past 6 months:

Hormone therapy (Progesterone or Letrozole)

Platinum-based chemotherapy (monotherapy or combination with taxanes, anthracyclines, cyclophosphamide)

Any other SACT
 
Answer To Question 3:
Hormone therapy (Progesterone or Letrozole) unable to answer
Platinum-based chemotherapy (monotherapy or combination with taxanes, anthracyclines, cyclophosphamide) <5
Any other SACT 0
 
Question Number 4:
Of the patients treated for endometrial cancer in the past 6 months with any SACT regimen, how many patients had high microsatellite instability (MSI-H) or mismatch repair deficiency (dMMR)?
 
Answer To Question 4:
<5
 
Question Number 5:
Does your trust participate in any clinical trials for the treatment of endometrial cancer? If so, can you please provide the name of each trial and the number of patients taking part.
 
Answer To Question 5:
NO
 
To return to the list of all the FOI requests please click here

Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.

Person Centred & Safe

Professional

Responsive

Friendly

Progressive

Salisbury NHS Foundation Trust, Salisbury District Hospital, Odstock Road, Salisbury, Wiltshire, SP2 8BJ
T: 01722 336262 E: sft.pals@nhs.net
© 2024 Salisbury NHS Foundation Trust
Trust Values